EVENTS
Where can you meet us?
Meet us at upcoming industry events to learn how our synthetic DNA solutions can accelerate your research and therapeutic development. Our team will be on hand to discuss your needs. Book a meeting or drop by our booth to connect
The Switch to Cell-Free DNA: Strategic and Regulatory Considerations for Advanced Therapies
Original broadcast: 11 DEC 2025
On-demand webinar
WATCH NOW ON DEMAND
This webinar features Amy Walker, Ph.D., CEO, joined by guest speaker Jenny Mellquist, Ph.D., for a focused discussion on the strategic, technical, and regulatory steps required to transition from plasmid DNA to synthetic, cell-free DNA for advanced therapies.
Session Focus
A practical overview of the strategic and regulatory considerations involved in updating your critical starting material to next-generation, cell-free DNA.
Key Topics
Critical regulatory and CMC requirements for material substitution
Practical considerations for implementing the change within a cGMP environment
Technical and logistical advantages of cell-free DNA over pDNA
If you're planning 2026 programs and want to explore how synthetic, cell-free DNA can accelerate timelines and improve product purity, click here to watch the webinar.
Sequence to Solution: Synthetic DNA Accelerating Advanced Therapies
Original broadcast: 31 MARCH 2026
On-demand webinar
WATCH NOW ON DEMAND
Discover how synthetic DNA is transforming advanced therapies, enabling faster development of personalized cancer vaccines and mRNA treatments from sequence to clinic.
Bringing together two pioneering companies, Neomatrix Biotech and HelixNano, this webinar features insights from Luigi Aurisicchio, CEO, and Marianna Keaveney, CSO, as they share how synthetic DNA is powering their development pipelines and accelerating therapeutic innovation.
Key topics:
Accelerating development of personalised cancer vaccines and mRNA therapies
The role of DNA quality, accuracy, and customisation in clinical success
Real-world examples of overcoming development bottlenecks
Benefits of flexible, fast, scalable construct design
To see how synthetic DNA is accelerating therapeutic innovation, click here to watch the webinar.
SynBioBeta
4-5 MAY 2026
San Jose, CA
Join us at SynBioBeta, taking place from May 4–7 in San Jose.
If you’re planning to attend, make sure to stop by Booth #311 at Spot #12 and connect with our team.
James Vang, VP BD and Curtis Alexander, BD Director will be there to connect, answer your questions, and discuss how we can support your next project with high-quality synthetic DNA solutions.
Swiss Biotech Day
4-5 MAY 2026
Basel, Switzerland
Join us at Swiss Biotech Day, taking place from May 4–7 in Basel.
Inna Uliyakina, BD Director, will be there to connect and discuss how our synthetic DNA solutions can help advance your cell and gene therapies.
If you would like to book a meeting with Inna, click here.
ASGCT
11-15 MAY 2026
Boston, MA
Join us at the ASGCT Annual Meeting, where we will share our latest advancements in synthetic DNA for gene therapies.
Oral presentation:
Amine Bouchareb, Director of Molecular Biology & Gene Editing – An enzymatic ssDNA platform for non-viral CRISPR gene editing (Abstract 158)
May 13, 9:00–9:15 AM | MCEC Room 210ABC
Poster presentations:
Celine Winckler, Associate Director of Viral Vector Applications – Improving rAAV safety profiles using bacterial backbone-free synthetic DNA templates (Abstract 1151)
May 12, 5:00–6:30 PM | Poster ReceptionEmily Young, Director of Scientific Applications – A thermostable synthetic DNA nanoparticle platform enables DNA-encoded tumour suppressor delivery (Abstract 3078)
May 14, 5:00–6:30 PM | Poster Reception
Also attending the event will be James Vang, VP BD and Curtis Alexander, BD Director
If you are attending, we’d love to connect. Schedule a meeting with our team to explore how 4basebio can support your next-generation therapies:
To book a meeting with James, click here.
To book a meeting with Curtis, click here.